| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |